Nanoparticles that exhibit localization to specific organs or to sites of disease via biological mechanisms, such as the RES or the EPR effect, are known as 'passive targeting agents'. One of the ...
Due to COVID-19 related supply-chain disruptions, Iodixanol and other contrast media agents have been in shortage nationwide. Fresenius Kabi announced the launch of Iodixanol Injection, a generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results